iShares Russell 2000 ETF (IWM)

104.49 -3.18  -2.95% NYSE Arca Apr 3, 16:59 Delayed 2m USD
View Full Chart
Price Chart

Key Stats

Net Asset Value 107.94
Discount or Premium to NAV -0.25%
Turnover Ratio 22.00%
1 Year Fund Level Flows 36.31M

Performance & Returns

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -28.44% -28.33% -27.58% 44
3M -34.80% -34.60% -36.63% 37
6M -26.33% -26.06% -30.40% 24
YTD -34.76% -34.67% -36.63% 37
1Y -29.23% -29.10% -31.92% 34
3Y -6.59% -6.56% -8.84% 27
5Y -1.53% -1.48% -3.01% 27
10Y 6.15% 6.19% 5.18% 25
15Y 5.31% 5.33% 4.55% 29
20Y -- -- 5.65% --
As of April 2, 2020. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 0.45% 0.58% 0.13%
Stock 99.55% 99.55% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of March 30, 2020

Region Exposure

Americas 99.60%
North America 99.35%
Latin America 0.25%
Greater Europe 0.20%
United Kingdom 0.04%
Europe Developed 0.08%
Europe Emerging 0.02%
Africa/Middle East 0.06%
Greater Asia 0.20%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.13%
Asia Emerging 0.07%
Market Classification
% Developed Markets 99.89%
% Emerging Markets 0.11%
As of March 30, 2020. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 3.31%
Communication Services 2.56%
Consumer Cyclical 7.37%
Consumer Defensive 4.25%
Energy 1.60%
Financial Services 15.72%
Healthcare 21.47%
Industrials 16.11%
Real Estate 8.33%
Technology 14.71%
Utilities 4.58%
As of March 30, 2020

Stock Market Capitalization

Giant 0.00%
Large 0.24%
Medium 20.05%
Small 67.54%
Micro 12.17%
As of March 30, 2020

Stock Style Exposure

Large Cap Value 0.00%
Large Cap Blend 0.00%
Large Cap Growth 0.25%
Mid Cap Value 3.97%
Mid Cap Blend 5.75%
Mid Cap Growth 10.77%
Small Cap Value 20.21%
Small Cap Blend 28.04%
Small Cap Growth 31.01%
As of March 30, 2020
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
TDOC Teladoc Health Inc 0.81% 156.25 -1.93%
NVCR NovoCure Ltd 0.42% 63.34 -4.44%
GNRC Generac Holdings Inc 0.39% 84.65 -2.12%
AMED Amedisys Inc 0.39% 176.68 -1.26%
LITE Lumentum Holdings Inc 0.38% 67.31 -4.06%
HAE Haemonetics Corp 0.35% 98.70 -1.10%
RGEN Repligen Corp 0.34% 98.64 +1.74%
TREX Trex Co Inc 0.34% 67.85 -10.55%
REXR Rexford Industrial Realty Inc 0.32% 36.03 -2.57%
TECD Tech Data Corp 0.32% 132.75 +0.93%
As of March 30, 2020
Advertisement

Basic Info

Investment Strategy
The investment seeks to track the investment results of the Russell 2000® Index, which measures the performance of the small-capitalization sector of the U.S. equity market. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the underlying index, but which the advisor believes will help the fund track the underlying index.
General
Security Type Exchange-Traded Fund
Equity Style Small Cap/Growth
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Small Blend
Prospectus Objective Small Company
Fund Owner Firm Name iShares
Benchmark Index
Russell 2000 TR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Alan Mason 3.88 yrs
Amy Whitelaw 1.58 yrs
Greg Savage 12.17 yrs
Jennifer Hsui 7.58 yrs
Rachel Aguirre 1.58 yrs

Net Fund Flows

1M 1.692B
3M -1.386B
6M -973.66M
YTD -1.386B
1Y 36.31M
3Y 1.200B
5Y 5.643B
10Y 12.08B
As of March 31, 2020

Risk Info

Beta (5Y) 1.258
Max Drawdown (All) 59.03%
Historical Sharpe Ratio (10Y) 0.4295
Historical Sortino (All) 0.3555
30-Day Rolling Volatility 83.60%
Daily Value at Risk (VaR) 1% (All) 3.84%
Monthly Value at Risk (VaR) 1% (All) 19.06%

Fundamentals

Dividend Yield TTM (4-3-20) 2.00%
30-Day SEC Yield --
7-Day SEC Yield --
Weighted Average PE Ratio 17.11
Weighted Average Price to Sales Ratio 1.148
Weighted Average Price to Book Ratio 1.961
Weighted Median ROE 4.17%
Weighted Median ROA -0.90%
Forecasted Dividend Yield 1.56%
Forecasted PE Ratio 15.71
Forecasted Price to Sales Ratio 1.056
Forecasted Price to Book Ratio 1.761
Number of Holdings 1985
As of March 30, 2020

Growth Estimates

Forecasted 5 Yr Earnings Growth 11.54%
Forecasted Book Value Growth -53.20%
Forecasted Cash Flow Growth 4.76%
Forecasted Earnings Growth 7.01%
Forecasted Revenue Growth -54.26%
As of March 30, 2020

Comparables

Edit

Attributes

Key Dates
Inception Date 5/22/2000
Termination Date
Last Annual Report Date 3/31/2019
Last Prospectus Date 8/1/2018
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.